Dr. Vladimir Zelenko, the Jewish doctor who treated coronavirus patients with 99% success rate using hydroxychloroquine, published a new HCQ study | Tech News

It’s been while since we wrote about Dr. Vladimir “Zev” Zelenko. We first wrote about Zev after his first announcement in March that he successfully treated 350 coronavirus patients with 100% success using Hydroxychloroquine Sulfate. Since then, hydroxychloroquine has become the most divisive and controversial drug in America.

Dr. Zelenkzo is a Hasidic Jewish doctor and a board-certified family practitioner in New York. He claimed to have been treating coronavirus patients since the beginning of March using a combination of three drug regimen: hydroxychloroquine (an anti-malaria drug), azithromycin, and zinc sulfate. Seven countries, including Israel, Brazil, and Russia are already following Dr. Zelenkzo drug regimen. As we reported earlier today, Brazil’s president, Jair Bolsonaro, is also using taking hydroxychloroquine.

Since early March, Dr. Zelenkzo had treated over 1,500 people with coronaviruslike symptoms. It all started after Dr. Zelenkzo developed an experimental treatment using a cocktail of three drug regimen: hydroxychloroquine (an anti-malaria drug), azithromycin, and zinc sulfate. Dr. His out-patient treatment regimen, which he said costs only $12, includes:

1. Hydroxychloroquine 200mg twice a day for 5 days
2. Azithromycin 500mg once a day for 5 days
3. Zinc sulfate 220mg once a day for 5 days

In a March 21 video, which was addressed to President Donald Trump and eventually posted to YouTube and Facebook, Dr. Zelenkzo said: “I’m seeing tremendous positive results.”

“What bothers me most is the fact HCQ worked this whole time. The media said it would literally kill you if you took it simply because POTUS promoted it…If only we could set politics aside…thousands of lives likely would have been saved.”

Now, Dr. Zelenko has published a new study on hydroxychloroquine. The study, which is submitted for peer review, describes outcomes of patients with coronavirus disease 2019 (COVID-19) in the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and azithromycin (the triple therapy) dependent on risk stratification. Dr. Zelenko claimed to have 99 percent success rate with his hydroxychloroquine treatment regimen.

“Facts, not fear. COVID is very real. But if we treat it early and the right way, it’s nothing to fear. I saw early use of zinc, hydroxychloroquine, and azithromycin result in an over 99% survival rate in my COVID patients. Don’t let professional scaremongers dictate the narrative,” Dr. Zelenkzo said.

Dr. Zelenkzo also shares the result of study in a new video with Dr. Drew. He went on to answer questions about school reopening, and the need for the country to focus on the truth of medical information and not inject politics into science.

Below is  video of his interview with Dr. Drew.

Source link

Leave a Reply